Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: GOG 0244: The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors and Impact in Newly Diagnosed Patients

 


GOG 0244: The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors and Impact in Newly Diagnosed Patients


Trial Focus

Female Reproductive Cancer

Objective

         This is a clinical trial designated to learn more about how often women with your type of cancer may develop lower extremity lymphedema (swelling in the legs or a swollen leg) after undergoing surgery to remove your tumor and surrounding tissue for gyneco

IRB Protocol #

13-1706

Trial Status

Archived

Principle Investigator

SUSAN DAVIDSON

Sponsor

GOG

Contact

REBECCA KISSANE at (720)848-7202 or REBECCA.KISSANE@UCDENVER.EDU

Location

University of Colorado Hospital University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : A screening period will determine eligibility. Treatment period can last up to 2 years. A follow up period will consist of an examination 4-6 weeks after surgery, then every three months during months 3-12, and every 6 months during months13-24. // Eligibility criteria include but are not limited to 18 years or older with cervical, vulvar, or uterine cancer.Eligibility criteria include but are not limited to 18 years or older with cervical, vulvar, or uterine cancer.